气囊ARDS:气囊烟雾暴露导致ARDS
Venkat Raman Kola1, Venkata Nagarjuna Maturu2,3, Nithin Pinninti4
1Critical Care Medicine, Yashoda Group of Hospitals, Hyderabad, Telangana, India dr_kvraman@yahoo.co.in.
BMJ case reports
|March 13, 2025
概括
气囊烟雾可能导致严重的肺损伤,导致化学肺炎. 及时诊断和治疗,包括类固醇和机械通风,对于从这种由安全气囊引起的呼吸困扰中恢复至关重要.
科学领域:
- 肺部医学 肺部医学
- 毒理学 毒理学 毒理学
- 紧急医疗 紧急医疗
背景情况:
- 道路交通事故可能导致暴露于安全气囊部署烟雾.
- 气囊烟雾,主要含有亚酸,可以导致严重的呼吸困扰.
- 最初的症状可能会模仿下呼吸道感染,延迟诊断.
研究的目的:
- 在暴露于安全气囊烟雾后报告严重的化学肺炎病例.
- 突出诊断挑战和有效的管理策略,为这种情况.
- 强调在相关的临床场景中考虑化学肺炎的重要性.
主要方法:
- 一个男性患者的病例介绍,该患者在道路交通事故后出现呼吸困难.
- 诊断工作包括排除感染,自身免疫性疾病和肺部受伤.
- 治疗包括重症监护室的入院,机械通风 (MV),脉冲类固醇和倾斜的定位.
主要成果:
- 患者患有严重的呼吸困难,归因于暴露于酸的化学肺炎.
- 最初的感染治疗无效,但脉冲类固醇和MV期间的倾斜定位导致了改善.
- 呼吸道症状完全消失,23天后成功输出输出管并出院.
结论:
- 暴露于酸后的化学肺炎是空气囊部署后呼吸困难患者的关键考虑因素.
- 早期识别和积极管理,包括类固醇和像MV这样的支持性护理,对于有利的结果至关重要.
- 这一案例强调了对来自安全气囊化学品的有毒吸入损伤的高度临床怀疑的必要性.
相关概念视频
Acute Respiratory Failure-IV
116
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
116
Acute Respiratory Failure-I
158
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
158
Acute Respiratory Failure-III
150
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
150
Acute Respiratory Failure-II
158
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
158
Pneumothorax-I
165
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
165
Acute Respiratory Failure-V
113
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
113


